Wyong Rugby Leagues kicks goal to help end melanoma
28 March 2017
Wyong Rugby Leagues kicks goal to help end melanoma Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
The club has generously donated $60,000 to Melanoma Institute Australia to enable purchase of a new slide stainer which is vital for monitoring individual patient responses to melanoma treatment. The new equipment will help ensure life-saving clinical decisions can be made, including switching therapies should resistance begin to develop.
CEO of Melanoma Institute Australia, Carole Renouf, said the support from Wyong Rugby League Club Group was particularly relevant given the region had been identified as a melanoma hotspot.
“Wyong and the Central Coast are among 28 melanoma hotspots around the state, meaning they have some of the highest rates of melanoma, significantly above the state average,” Ms Renouf said.
“Melanoma is the most common cancer affecting Australians aged 15-39 and kills more 20-39 year olds than any other single cancer. Incidence in the over the 60s is also increasing.
“The support from Wyong Rugby League Club Group means we are equipped with the latest equipment and technology to ensure melanoma patients, many of whom come from the Wyong and Central Coast areas, receive the best possible treatment,” she said.
CEO of Wyong Rugby League Club Group, Michael Coghlan, said with seven venues located on the Central Coast and 50,000 members, it had always been a core focus of the group to support local organisations, sporting groups and the greater community. “We recognise that the Central Coast is a melanoma hotspot and we look forward to growing our partnership and raising awareness with Melanoma Institute Australia,” he said.
The partnership between MIA and Wyong Rugby League Club Group also extends to support of The Longest Melanoma March, a 1200 kilometre trek from Brisbane to Sydney by MIA Community Coordinator and melanoma survivor Jay Allen. Wyong Rugby League Club Group hosted a range of fundraising activities at the Bateau Bay Bowling Club today to welcome Jay as he walked through the Central Coast.
"We sincerely thank Wyong Rugby League Club Group for this generous support,” Ms Renouf said. “It will help us raise awareness about sun-smart behaviour to reduce melanoma risk, and will also assist us in raising vital funds for ongoing research into melanoma prevention and treatment,” she said.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.